Researchers from Tel Aviv University (TAU) and the Tel Aviv Sourasky Medical Center (Ichilov) have measured subjects’ memory without asking whether they remembered something or not, just by tracking their eye movements as they watched animation videos. The study demonstrated that people actually remember more than they report. Moreover, this method can be used to… Read More
Researchers at the Gray Faculty of Medical and Health Sciences at Tel Aviv University (TAU) have introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. The treatment constitutes an improvement over existing strategies, demonstrating enhanced efficiency and holding promise for treating a wide range of mutations… Read More
Surgeons in Israel will soon implant a bioengineered, personalized human spinal cord into a paralyzed patient, with the goal of enabling the patient to rise from a wheelchair and walk again. The research behind this medical advance was led by Professor Tal Dvir, Head of the Sagol Center for Regenerative Biotechnology and Head of the… Read More
A new study from the Gray Faculty of Medical and Health Sciences at Tel Aviv University (TAU) may mark a breakthrough in the treatment of Eosinophilic Esophagitis (EoE), a chronic inflammatory disease of the esophagus caused by food allergies. EoE leads to difficulty swallowing, chest and abdominal pain, and even growth delays in children. Its… Read More
Researchers from Tel Aviv University (TAU) and Sheba Medical Center have grown human kidney organoids, a synthetic 3D organ culture, from tissue stem cells in the laboratory, mirroring human fetal kidney development for the first time. The current model has matured and stayed stable for over a half a year. Previous kidney organoids mimicking development… Read More
Researchers from Tel Aviv University (TAU) and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. In the groundbreaking study, the researchers tested the vaccine’s resistance to the virulent pathogen that causes the disease and… Read More
Researchers from Tel Aviv University (TAU) and Sheba Tel Hashomer Medical Center have developed an innovative bioengineered skin equivalent for grafting in burn victims. The bioengineered skin produced from the patient’s own cells is more stable, robust, and flexible than current treatments, making it easier to handle. In a full-thickness wound model, it achieved wound… Read More
Researchers at Tel Aviv University (TAU) found that immune system cells called neutrophils are recruited by the tumor environment in advanced breast cancer to support tumor progression in the later stages of the disease. They believe that neutrophils, which are unique to the tumor environment, may serve as targets for the development of new drugs and… Read More